Y10S 530/862
Involving ige or igd
Official title: involving IgE or IgD
Y10S530/862 (Involving ige or igd) appears on 72 US grants and 32 published applications in this corpus.
Search patents in Y10S- Granted patents
- 72
- Published applications
- 32
- Assignees
- 47
- Inventors
- 109
- Latest grant
- 2 Feb 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 7 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 3 |
| 2004 | 0 | 1 |
| 2005 | 2 | 2 |
| 2006 | 0 | 1 |
| 2007 | 3 | 3 |
| 2008 | 0 | 1 |
| 2009 | 2 | 3 |
| 2010 | 1 | 2 |
| 2011 | 2 | 3 |
| 2012 | 1 | 4 |
| 2013 | 3 | 2 |
| 2014 | 4 | 3 |
| 2015 | 4 | 3 |
| 2016 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- IgE CH3 peptide vaccine2 Feb 2016US 9,249,233 B2Pfizer Vaccines LLC
- Methods for treating chronic obstructive pulmonary disease7 Apr 2015US 8,999,339 B2
- C(epsilon)mX peptides for inducing immune responses to human mIgE on B lymphocytes10 Mar 2015US 8,974,794 B2Academia Sinica
- Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease3 Feb 2015US 8,945,566 B2Quest Pharmatech Inc.
- Protein-based assays for screening of the IgE-receptor interaction6 Jan 2015US 8,927,695 B2The Board of Trustees of the Leland Stanford Junior University
- In vitro assay for quantitating secreted antibodies in lymphocyte supernatant for evaluation of vaccine or antigen induced specific antibody secretion from ex vivo circulating antibody-secreting lymphocytes24 Sep 2015US 2015/0268225 A1
- Methods for treating chronic obstructive pulmonary disease27 Aug 2015US 2015/0239989 A1
- IGE CH3 Peptide Vaccine30 Apr 2015US 2015/0118256 A1Pfizer Vaccines LLC
- Methods for treating chronic obstructive pulmonary disease25 Sep 2014US 2014/0286942 A1
- Anti-c (epsilon)mx antibodies capable of binding to human mige on b lymphocytes7 Aug 2014US 2014/0220042 A1Academia Sinica
Most cited
By later US patents
- Species-linked diamine triacetic acids and their chelates123US 4,352,751 AAnalytical Radiation Corporation · 1982
- Antigenic epitopes of IgE present on B cell but not basophil surface99US 5,091,313 ATanox Biosystems, Inc. · 1992
- Immunoglobulin variants58US 5,994,514 AGenentech, Inc. · 1999
- Enzyme conjugates48US 4,002,532 A1977
- Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore46US 4,940,782 AG. D. Searle & Co. · 1990